Introduction: Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with high morbidity and mortality but without available evidence-based therapies. It is essential to investigate changes in gene expression profiles in preclinical HFpEF animal models, with the aim of searching for novel therapeutic targets. Methods: Wild-type male C57BL/6J mice were administrated with a combination of high-fat diet (HFD) and inhibition of constitutive nitric oxide synthase using N-nitro-l-arginine methyl ester (l-NAME) for 5 and 7 weeks. RNA sequencing was conducted to detect gene expression profiles, and bioinformatic analysis was performed to identify the core genes, pathways, and biological processes involved. Results: A total of 1,347 genes were differentially expressed in the heart at week 5 and 7 post-intervention. Gene Ontology enrichment analysis indicated that these greatly changed genes were involved mainly in cell adhesion, neutrophil chemotaxis, cell communication, and other functions. Using hierarchical cluster analysis, these differentially expressed genes were classified into 16 profiles. Of these, three significant profiles were ultimately identified. Gene co-expression network analysis suggested troponin T type 1 (Tnnt1) directly regulated 31 neighboring genes and was considered to be at the core of the associated gene network. Conclusion: The combined application of RNA sequencing, hierarchical cluster analysis, and gene network analysis identified Tnnt1 as the most important gene in the development of HFpEF.

1.
Ponikowski
P
,
Voors
AA
,
Anker
SD
,
Bueno
H
,
Cleland
JGF
,
Coats
AJS
, et al
.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
.
Eur Heart J
.
2016
;
37
(
27
):
2129
200
.
2.
Little
WC
,
Zile
MR
.
HFpEF: cardiovascular abnormalities not just comorbidities
.
Circ Heart Fail
.
2012
;
5
(
6
):
669
71
.
3.
Triposkiadis
F
,
Giamouzis
G
,
Parissis
J
,
Starling
RC
,
Boudoulas
H
,
Skoularigis
J
, et al
.
Reframing the association and significance of co-morbidities in heart failure
.
Eur J Heart Fail
.
2016
;
18
(
7
):
744
58
.
4.
Chioncel
O
,
Lainscak
M
,
Seferovic
PM
,
Anker
SD
,
Crespo-Leiro
MG
,
Harjola
VP
, et al
.
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry
.
Eur J Heart Fail
.
2017
;
19
(
12
):
1574
85
.
5.
Beale
AL
,
Meyer
P
,
Marwick
TH
,
Lam
CSP
,
Kaye
DM
.
Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction
.
Circulation
.
2018
;
138
(
2
):
198
205
.
6.
Shah
KS
,
Xu
H
,
Matsouaka
RA
,
Bhatt
DL
,
Heidenreich
PA
,
Hernandez
AF
, et al
.
Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes
.
J Am Coll Cardiol
.
2017
;
70
(
20
):
2476
86
.
7.
Schiattarella
GG
,
Altamirano
F
,
Tong
D
,
French
KM
,
Villalobos
E
,
Kim
SY
, et al
.
Nitrosative stress drives heart failure with preserved ejection fraction
.
Nature
.
2019
;
568
(
7752
):
351
6
.
8.
Yim
J
,
Cho
H
,
Rabkin
SW
.
Gene expression and gene associations during the development of heart failure with preserved ejection fraction in the Dahl salt sensitive model of hypertension
.
Clin Exp Hypertens
.
2018
;
40
(
2
):
155
66
.
9.
Zhang
JS
,
Zhang
YL
,
Wang
HX
,
Xia
YL
,
Wang
L
,
Jiang
YN
, et al
.
Identification of genes related to the early stage of Angiotensin II-induced acute renal injury by microarray and integrated gene network analysis
.
Cell Physiol Biochem
.
2014
;
34
(
4
):
1137
51
.
10.
Dang
MQ
,
Zhao
XC
,
Lai
S
,
Wang
X
,
Wang
L
,
Zhang
YL
, et al
.
Gene expression profile in the early stage of angiotensin II-induced cardiac remodeling: a time series microarray study in a mouse model
.
Cell Physiol Biochem
.
2015
;
35
(
2
):
467
76
.
11.
Lee
DI
,
Zhu
G
,
Sasaki
T
,
Cho
GS
,
Hamdani
N
,
Holewinski
R
, et al
.
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
.
Nature
.
2015
;
519
(
7544
):
472
6
.
12.
Zhang
YL
,
Zhi
LY
,
Zou
LX
,
Chen
C
,
Bai
J
,
Lin
QY
, et al
.
Analysis of genes related to angiotensin II-induced arterial injury using a time series microarray
.
Cell Physiol Biochem
.
2018
;
48
(
3
):
983
92
.
13.
Wang
L
,
Zhang
YL
,
Lin
QY
,
Liu
Y
,
Guan
XM
,
Ma
XL
, et al
.
CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration
.
Eur Heart J
.
2018
;
39
(
20
):
1818
31
.
14.
Lam
CSP
,
Voors
AA
,
de Boer
RA
,
Solomon
SD
,
van Veldhuisen
DJ
.
Heart failure with preserved ejection fraction: from mechanisms to therapies
.
Eur Heart J
.
2018
;
39
(
30
):
2780
92
.
15.
Kuwahara
F
,
Kai
H
,
Tokuda
K
,
Takeya
M
,
Takeshita
A
,
Egashira
K
, et al
.
Hypertensive myocardial fibrosis and diastolic dysfunction: another model of inflammation
.
Hypertension
.
2004
;
43
(
4
):
739
45
.
16.
Kai
H
,
Kuwahara
F
,
Tokuda
K
,
Imaizumi
T
.
Diastolic dysfunction in hypertensive hearts: roles of perivascular inflammation and reactive myocardial fibrosis
.
Hypertens Res
.
2005
;
28
(
6
):
483
90
.
17.
Savoia
C
,
Schiffrin
EL
.
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
.
Clin Sci
.
2007
;
112
(
7
):
375
84
.
18.
Paulus
WJ
,
Tschöpe
C
.
A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation
.
J Am Coll Cardiol
.
2013
;
62
(
4
):
263
71
.
19.
Mondal
A
,
Jin
JP
.
Protein structure-function relationship at work: learning from myopathy mutations of the slow skeletal muscle isoform of troponin T
.
Front Physiol
.
2016
;
7
:
449
.
20.
Wei
B
,
Jin
JP
.
TNNT1, TNNT2, and TNNT3: isoform genes, regulation, and structure-function relationships
.
Gene
.
2016
;
582
(
1
):
1
13
.
21.
Chirinos
JA
,
Zamani
P
.
The nitrate-nitrite-NO pathway and its implications for heart failure and preserved ejection fraction
.
Curr Heart Fail Rep
.
2016
;
13
(
1
):
47
59
.
22.
Holtwick
R
,
van Eickels
M
,
Skryabin
BV
,
Baba
HA
,
Bubikat
A
,
Begrow
F
, et al
.
Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A
.
J Clin Invest
.
2003
;
111
(
9
):
1399
407
.
23.
Takimoto
E
,
Champion
HC
,
Li
M
,
Belardi
D
,
Ren
S
,
Rodriguez
ER
, et al
.
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
.
Nat Med
.
2005
;
11
(
2
):
214
22
.
You do not currently have access to this content.